Dcm Advisors, LLC Pfizer Inc Transaction History

Dcm Advisors, LLC

$188 Million
Q2 2024

A detailed history of Dcm Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dcm Advisors, LLC holds 24,656 shares of PFE stock, worth $721,681. This represents 0.37% of its overall portfolio holdings.

Number of Shares

24,656

Previous 108,128 77.2%

Holding current value

$721,681

Previous $3 Million 77.03%

% of portfolio

0.37%

Previous 1.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $2.11 Million - $2.47 Million	-83,472 Reduced 77.2%	24,656 $689,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $6,446 - $7,402	249 Added 0.23%	108,128 $3 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.24 Million - $1.61 Million	47,358 Added 78.25%	107,879 $3.11 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $1,123 - $1,312	-35 Reduced 0.06%	60,521 $2.01 Million
Q2 2023 Sep 12, 2023	SELL	$36.12 - $41.79 $1,408 - $1,629	-39 Reduced 0.06%	60,556 $2.22 Million
Q1 2023 Sep 12, 2023	SELL	$39.39 - $51.28 $15,125 - $19,691	-384 Reduced 0.63%	60,595 $2.47 Million
Q4 2022 Sep 08, 2023	BUY	$41.75 - $54.5 $1.33 Million - $1.74 Million	31,933 Added 109.94%	60,979 $3.13 Million
Q3 2022 Sep 08, 2023	SELL	$43.76 - $53.42 $360,538 - $440,127	-8,239 Reduced 22.1%	29,046 $1.27 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $148,523 - $176,102	3,192 Added 9.36%	37,285 $1.96 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $137,341 - $170,183	-3,002 Reduced 8.09%	34,093 $1.77 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $507,326 - $752,027	12,278 Added 49.47%	37,095 $2.19 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $974,067 - $1.25 Million	24,817 New	24,817 $1.07 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $164B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.

Account